Clinical Study on the Intervention of Xuesaitong Soft Capsules in Post-Intervention Patients with Acute Coronary Syndrome and Clinical Research Protocol
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 400 participants.
Also called NCT06845254
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 400 participants
- Registry
-
NCT06845254
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT06845254. Randomized; double masking; primary purpose treatment. Start 2025-03-01 (anticipated); primary completion 2025-10-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Study on the Intervention of Xuesaitong Soft Capsules in Post-Intervention Patients with Acute Coronary Syndrome and Clinical Research Protocol
- Condition
- Acute Coronary Syndrome
- Intervention (Drug)
- Xuesaitong soft capsule (main ingredient is Panax notoginseng saponins)
- Intervention (Drug)
- placebo capsule
- Lead sponsor
- Xiyuan Hospital of China Academy of Chinese Medical Sciences
Record details
- Record id
cardio:ct-nct06845254- Content hash
e4c4e813fbdc3c2665bf5321f3db84a50730b49b3f90326568bdcacac3a11e58